Showing 1261-1270 of 1511 results for "".
- Johnson & Johnson Starts Phase 3 Study of COVID-19 Vaccine Candidatehttps://modernod.com/news/johnson-johnson-starts-phase-3-study-of-covid-19-vaccine-candidate/2478315/Johnson & Johnson launched a late-stage study of its COVID-19 vaccine candidate JNJ-78436735 following positive interim results from a phase 1/2a trial. The ENSEMBLE study will enroll up to 60,000 volunteers and will evaluate the safety and efficacy of a single vaccine dose versus placebo in
- Johnson & Johnson to Buy Momenta for $6.5 billionhttps://modernod.com/news/johnson-johnson-to-buy-momenta-for-6-5-billion/2478177/Johnson & Johnson entered into a definitive agreement to acquire Momenta Pharmaceuticals for $52.50 per share in cash, or approximately $6.5 billion, expanding its portfolio into autoantibody-driven autoimmune diseases. The transaction, which represents a premium of 70% to Momenta’s clo
- Why Johnson & Johnson is Investing in This Niche Telehealth Startuphttps://modernod.com/news/why-johnson-johnson-is-investing-in-this-niche-telehealth-startup/2478171/Pharmaceutical giant Johnson & Johnson is investing in direct-to-consumer telehealth company Thirty Madison. New York City-based Thirty Madison offers telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux, according to a FierceHealthcare
- Johnson & Johnson Vision Launches Tecnis Synergy and Tecnis Eyhance IOLs in Canadahttps://modernod.com/news/johnson-johnson-vision-launches-tecnis-synergy-and-tecnis-eyhance-iols-in-canada/2478160/Johnson & Johnson Vision announced Health Canada approval and July availability of its Tecnis Synergy and Tecnis Eyhance IOLs to the Canadian market. The Tecnis Synergy, originally launched in Europe in September 2019, delivers continuous high-cont
- Johnson & Johnson Forges $1-Billion Pact to Supply US with COVID-19 Vaccinehttps://modernod.com/news/johnson-johnson-forges-1-billion-pact-to-supply-us-with-covid-19-vaccine/2478133/Johnson & Johnson said it entered into an agreement with the US government for the large-scale domestic manufacturing and delivery of 100 million doses of its investigational SARS-CoV-2 vaccine Ad26.COV2.S for use in the country. Specifically, the US Biomedical Advanced Research and Developme
- Johnson & Johnson Vision Donates $320K to Support Practitioners and Schools of Optometry Impacted by COVID-19https://modernod.com/news/johnson-johnson-vision-donates-320k-to-support-practitioners-and-schools-of-optometry-impacted-by-covid-19/2477924/As part of ongoing initiatives to help support eye care in the wake of COVID-19, Johnson & Johnson Vision announced donations to Optometry Cares, the charitable foundation of The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation (AAOF). A
- Johnson & Johnson Vision Presents Myopia Research Findings at ARVOhttps://modernod.com/news/johnson-johnson-vision-presents-myopia-research-findings-reports-contact-lens-iol-and-equipment-data-at-arvo-annual-meeting/2479519/Johnson & Johnson Vision will present the first clinical research findings from its comprehensive myopia clinical research program with the Singapore Eye Research Institute (SERI) and Singapore National Eye Centre (SNEC), as well as new data on contact lens and surgical innovations, at the 20
- Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidatehttps://modernod.com/news/johnson-johnson-announces-acceleration-of-its-covid-19-vaccine-candidate/2477889/Johnson & Johnson announced that through its Janssen Pharmaceutical Companies division that it has accelerated the initiation of the phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Initially scheduled to begin in September, the tri
- Johnson & Johnson Vision Appoints Erin McEachren as Regional Vice President, Surgical, EMEAhttps://modernod.com/news/johnson-johnson-vision-appoints-erin-mceachren-as-regional-vice-president-surgical-emea/2477847/Johnson & Johnson Vision has appointed Erin McEachren to the position of Regional Vice President for Johnson & Johnson Surgical Vision, EMEA. In this role, Ms. McEachren will lead Johnson & Johnson’s high-performance surgical vision team to address the unmet needs of patients and eye
- Johnson & Johnson Vision Announces the US Launch of the Tecnis Multifocal Toric II IOLhttps://modernod.com/news/johnson-johnson-vision-announces-the-us-launch-of-the-tecnis-multifocal-toric-ii-iol/2477778/Johnson & Johnson Vision announced the US launch of the Tecnis Multifocal Toric II IOL, the first multifocal IOL approved on the new Tecnis Toric II platform. The square-edge Tecnis Multifocal Toric II implant features a new generation of frosted haptics, offering more surface texture and fri